Related Experiment Video
Updated: Aug 19, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Protein kinase Cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active
1Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, USA. kumunda@uthct.edu
Abstract:
Bacterial lipopolysaccharide can induce manganese superoxide dismutase (MnSOD) gene expression in a variety of cells. Paclitaxel (taxol) shares many properties of lipopolysaccharide. Here we report that paclitaxel can induce MnSOD gene expression in human lung adenocarcinoma cell line A549 in a time- and dose-dependent manner. Additional anticancer drugs, vinblastine and vincristine, also induced MnSOD gene expression. We have shown previously (Das, K. C., and White, C. W. (1997) J. Biol. Chem. 272, 14914-14920) that these drugs can activate protein kinase C (PKC). The PKC agonists thymeleatoxin (0.5 microM) and 12-deoxyphorbol 13-phenylacetate 20-acetate (dPPA; 10 nM) potently induced MnSOD gene expression. Calphostin C and GF109203X, both specific inhibitors of PKC, each inhibited MnSOD gene expression by anticancer agents. Down-regulation of PKC by prolonged treatment with phorbol 12-myristate 13-acetate (PMA) also inhibited induction of MnSOD by anticancer drugs, indicating an important role of PKC in MnSOD signaling by these agents. Of 11 PKC isoenzymes, only PKCdelta translocated to the cell membrane after stimulation with anticancer drugs. By contrast, dPPA, PMA, and thymeleatoxin caused translocation of PKCalpha, betaI, delta, and mu isotypes. Anticancer drug-stimulated cells also had increased total PKC activity in membrane and cytosolic fractions. Thus, paclitaxel, vinblastine, and vincristine each specifically activate PKCdelta, whereas PMA, thymeleatoxin, and dPPA activate multiple isoenzymes. PKCdelta was the only isoform activated by each agent in both groups of compounds effective in MnSOD induction.
Insights
Anticancer drugs like paclitaxel activate protein kinase C delta (PKCδ), inducing manganese superoxide dismutase (MnSOD) gene expression. This highlights PKCδ
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Bacterial lipopolysaccharide and paclitaxel (taxol) can induce manganese superoxide dismutase (MnSOD) gene expression.
- Anticancer drugs share properties with lipopolysaccharide, suggesting a common signaling pathway.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) in paclitaxel- and other anticancer drug-induced MnSOD gene expression.
- To identify specific PKC isoenzymes involved in this signaling pathway.
Main Methods:
- Treatment of human lung adenocarcinoma cells (A549) with paclitaxel, vinblastine, vincristine, and PKC activators/inhibitors.
- Analysis of MnSOD gene expression, PKC activity, and PKC isoenzyme translocation.
- Down-regulation of PKC using phorbol 12-myristate 13-acetate (PMA).
Main Results:
- Paclitaxel, vinblastine, and vincristine induced MnSOD gene expression in a time- and dose-dependent manner.
- PKC activation was crucial for drug-induced MnSOD expression, as shown by inhibition with PKC inhibitors and PKC down-regulation.
- Anticancer drugs specifically activated PKCdelta, while other agents activated multiple PKC isoenzymes.
Conclusions:
- Protein kinase C delta (PKCδ) plays a specific role in mediating MnSOD gene induction by anticancer drugs like paclitaxel.
- Understanding this pathway could lead to novel therapeutic strategies targeting oxidative stress in cancer.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Stabilize Microtubules
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Drugs that Destabilize Microtubules
MAPK Signaling Cascades

